Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VINORELBINA MEDAC 80 MG CAPSULAS BLANDAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/VINORELBINA MEDAC 80 MG CAPSULAS BLANDAS EFG

Approved

STANDARD

VINORELBINA MEDAC 80 MG CAPSULAS BLANDAS EFG

Medac Gesellschaft Für Klinische Spezialpräparate Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 23, 2022
Approval ID: 21a17750e2462616
Company: Medac Gesellschaft Für Klinische Spezialpräparate Gmbh
Type: Standard

Approval Details

Approval Id: 21a17750e2462616
Drug Cima Aemps Name: VINORELBINA MEDAC 80 MG CAPSULAS BLANDAS EFG
Register Number: 87420
Holder Company Name: Medac Gesellschaft Für Klinische Spezialpräparate Gmbh
Marketing Company Name: Laboratorios Gebro Pharma S.A.
Authorization Date: 2022-05-23
Dosage Form: CÁPSULA BLANDA
Dose: 80 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Medac Gesellschaft Für Klinische Spezialpräparate Gmbh

Active Ingredients

VINORELBINA TARTRATO

110,8 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 23, 2022

Approval ID

21a17750e2462616

Type

Standard

Back to CIMA-AEMPS Approvals